Live Events
Algorithms
Breast Cancer
2022
2023
2024
2025
GI
2022
2023
2024
2025
GU
2023
2024
2025
Gynecology
2024
Hematology
2023
2024
2025
Lung Cancer
2023
2024
2025
Melanoma
2023
2024
2025
NET
2024
2025
Supportive Care
2024
Conferences
AACR
2023
ASCO
2022
2023
2024
2025
ASH
2022
2023
2024
ESMO
2022
2023
2024
ELCC
2025
GI ASCO
2024
2025
GU ASCO
2023
2024
2025
SABCS
2022
2023
2024
WCLC
2022
2023
2024
2025
Journal club
Breast
2022
2023
2024
GI
2023
2024
2025
GU
2023
2024
2025
Hematology
2024
2023
Lung Cancer
2024
2025
Challenging Cases
2025
Tox Check
2024
2025
Multi-D Rounds
Contact
2024
2025
Live Events
Algorithms
Breast Cancer
2022
2023
2024
2025
GI
2022
2023
2024
2025
GU
2023
2024
2025
Gynecology
2024
Hematology
2023
2024
2025
Lung Cancer
2023
2024
2025
Melanoma
2023
2024
2025
NET
2024
2025
Supportive Care
2024
Conferences
AACR
2023
ASCO
2022
2023
2024
2025
ASH
2022
2023
2024
ESMO
2022
2023
2024
ELCC
2025
GI ASCO
2024
2025
GU ASCO
2023
2024
2025
SABCS
2022
2023
2024
WCLC
2022
2023
2024
2025
Journal club
Breast
2022
2023
2024
GI
2023
2024
2025
GU
2023
2024
2025
Hematology
2024
2023
Lung Cancer
2024
2025
Challenging Cases
2025
Tox Check
2024
2025
Multi-D Rounds
Contact
2024
2025
Search
Durvalumab FDA approval
Home
Durvalumab FDA approval
Your experience on this site will be improved by allowing cookies
Cookie Policy
Allow cookies
